NEW YORK, July 24, 2025 (GLOBE NEWSWIRE) -- Blade Air Mobility, Inc. (Nasdaq: BLDE, “Blade” or the “Company”), will release financial results for the second quarter ended June 30, 2025 on Tuesday, August 5, 2025 before the market opens. The company will hold a conference call the same day at 8:00 am Eastern Time to discuss the results. The call will be hosted by Rob Wiesenthal, Blade’s Chief Executive Officer, and Will Heyburn, Blade’s Chief Financial Officer, and will include a question-and-answer session ...

Group 1: LATAM Airlines Group S.A. (LTM) - LATAM Airlines Group S.A. is a passenger and cargo air transportation services company with a Zacks Rank 1 [1] - The Zacks Consensus Estimate for LATAM's current year earnings has increased by 22.3% over the last 60 days [1] - LATAM has a PEG ratio of 0.62, which is lower than the industry average of 0.64, and possesses a Growth Score of A [1] Group 2: Unisys Corporation (UIS) - Unisys Corporation is an information technology solutions company with a Zacks Rank 1 [2] - The Zacks Consensus Estimate for Unisys's current year earnings has increased by 132% over the last 60 days [2] - Unisys has a PEG ratio of 0.51, significantly lower than the industry average of 2.84, and possesses a Growth Score of B [2] Group 3: Great Lakes Dredge & Dock Corporation (GLDD) - Great Lakes Dredge & Dock Corporation is a dredging services company with a Zacks Rank 1 [3] - The Zacks Consensus Estimate for Great Lakes Dredge & Dock's current year earnings has increased by 39.1% over the last 60 days [3] - Great Lakes Dredge & Dock has a PEG ratio of 1.00, compared to the industry average of 6.87, and possesses a Growth Score of A [3]

Blade Air Mobility (BLDE) Conference Summary Company Overview - Blade Air Mobility has been operational for eleven years, initially focusing on helicopter passenger transport in New York and expanding to European markets such as Monaco, Nice, Cannes, and Geneva [1][2] - The company aims to transition from helicopters to electric vertical takeoff and landing (eVTOL) aircraft, leveraging an asset-light model that allows for future aircraft swaps [2][4] Industry Dynamics - The transition to eVTOL is expected to occur soon, with potential commercialization timelines for manufacturers like Adobe and Archer projected for late 2025 to early 2026 in the Middle East and late 2027 to early 2028 in the U.S. [10][11] - Blade is well-positioned to capitalize on this transition due to its established infrastructure and technology stack, which includes heliports in key markets [12][14] Key Business Segments Passenger Transport - Blade has successfully penetrated the passenger market, offering competitive pricing that has attracted a significant customer base [11] - The company has broken through pricing barriers, offering a $95 annual airport pass for frequent flyers [11] Medical Transport - Blade is the largest air transporter of human organs in the U.S., with a business generating approximately $150 million, surpassing its passenger transport revenue [5][6][37] - The medical segment is expected to grow in double digits, with a target margin expansion from 15% to high teens due to increased control over owned jets [34][35] - Blade holds about 30-35% of the organ transport market, indicating significant growth potential [37] Technological Advancements - The company is exploring the integration of AI in operations, aiming for enhanced safety and efficiency in future eVTOL aircraft [21][22] - Blade does not manufacture its own aircraft but collaborates with established manufacturers like Bell and Airbus [23] Financial Performance - Blade is ahead of its profitability projections, with adjusted EBITDA expected to exceed $10 million in 2025, up from just over $1 million last year [43][45] - The company maintains a strong financial position with $120 million in cash and zero debt, focusing on strategic acquisitions in the medical sector [40][42] Strategic Initiatives - Blade is actively seeking acquisitions that can enhance its medical transport capabilities and leverage existing hospital relationships [40][42] - The company is involved in various high-profile events to increase brand recognition and attract new customers, such as the Ryder Cup and major music festivals [28][29] Conclusion - Blade Air Mobility is strategically positioned to lead the transition to eVTOL aircraft while maintaining a strong foothold in the medical transport sector, showcasing impressive financial growth and operational efficiency [43][45]

Core Viewpoint - Blade Mobility Inc. has seen a significant stock increase of over 18% following the release of its first-quarter earnings, highlighting positive financial performance and growth potential in the air mobility sector [1][3]. Company Overview - Blade Mobility operates in the air transport sector, offering services through a fleet that includes helicopters, private jets, turboprops, and amphibious seaplanes. The business is divided into two main verticals: Medical Services (58% of revenue) and Passenger Services (42% of revenue) [2][3]. Financial Performance - The company reported revenue of $54.3 million, exceeding expectations of $49.3 million, marking a 10% increase. The earnings per share showed a loss of four cents, which was better than the anticipated loss of 11 cents. Notably, Blade achieved its first-ever EBITDA profit of $0.1 million in the passenger segment [3][4]. - Blade reaffirmed its full-year revenue guidance of $245 million to $265 million, indicating a potential 2% year-over-year gain, driven by reduced aircraft maintenance and ongoing cost-saving measures [4]. Market Position and Future Outlook - Blade Mobility went public via a SPAC in 2020 and, despite facing challenges in the past, has shown resilience with a stock recovery from its 52-week low. The recent earnings report has positioned the stock above its 200-day simple moving average, suggesting bullish momentum [5][7]. - The air mobility sector is expanding, with growing interest in eVTOLs. Blade's core business in organ transport provides a significant first-mover advantage, making it less vulnerable to competition from companies like Joby Aviation and Archer Aviation [8]. - Analysts project a 12-month stock price forecast of $6.25, representing an 80.64% upside from the current price of $3.46, with a consensus indicating a bullish sentiment towards the stock [9][10].

Blade Air Mobility (BLDE) FY Conference May 14, 2025 03:40 PM ET Speaker0 Okay. Good afternoon, and, welcome to, JPMorgan's fifty third annual, tech conference. My name is Bill Peterson, Clean Tech Analyst. And we're pleased to have the team from Blade here. We have Matt Schneider, the VP of Investor Relations and Strategic Finance. Matt, thanks for joining the conference. Speaker1 Bill, thanks for having me at conference. Speaker0 Maybe as an introduction, we just had earnings here recently. Maybe we can g ...

Blade Air Mobility (BLDE) Q1 2025 Earnings Call May 12, 2025 08:00 AM ET Company Participants Mathew Schneider - Vice President of Investor Relations and Strategic FinanceRobert Wiesenthal - CEO & DirectorWilliam Heyburn - CFO & Head of Corporate DevelopmentJason Helfstein - Managing Director - Head of Internet ResearchLaura Li - Equity Research AssociateMahima Kakani - Equity Research AssociateJon Hickman - Managing Director, Equity Research Conference Call Participants Ben Klieve - Senior Equity Research ...

Investor Presentation May 2025 FORWARD LOOKING STATEMENTS This investor presentation contains "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that are not historical facts and may be identified by the use of words such as "will", "anticipate", "believe", "could", "continue", "expect", "estimate", "may", "plan", "outlook", "future", "target", and "project" and other simil ...

Group 1: Archer Aviation - Archer Aviation has faced stock volatility but continues to achieve significant milestones in 2025, indicating potential for future growth [3][5] - Recent developments include plans for air taxi services in Abu Dhabi and a $30 million agreement with Ethiopian Airlines for eVTOL aircraft [4] - The company is progressing towards receiving necessary FAA certifications, positioning itself as a disruptor in urban air transport [5] Group 2: PureCycle Technologies - PureCycle Technologies, a leader in plastic recycling, has seen stock declines not due to company missteps but general market sentiment [6][7] - The company has started generating revenue, including a notable sale of 500,000 pounds of resin to Drake Extrusion, validating its technology [8] - Progress at the Ironton recycling facility has ramped up operations to 88% of capacity, with an annual production capacity of 107 million pounds of resin [9] Group 3: VanEck Semiconductor ETF - The VanEck Semiconductor ETF offers a conservative approach to gaining exposure to the AI sector amidst recent market sell-offs [10] - Major holdings include Nvidia and Taiwan Semiconductor Manufacturing, which together account for about 30% of the fund [11] - The ETF has a total of 26 holdings, with the top five representing nearly 50% of the fund, and it provides annual distributions [12]

NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- Blade Air Mobility, Inc. (Nasdaq: BLDE, “Blade” or the “Company”), will release financial results for the first quarter ended March 31, 2025 on Monday, May 12, 2025 before the market opens. The company will hold a conference call the same day at 8:00 am Eastern Time to discuss the results. The call will be hosted by Rob Wiesenthal, Blade’s Chief Executive Officer, and Will Heyburn, Blade’s Chief Financial Officer, and will include a question-and-answer session fo ...

Market Overview - The stock market is showing positive momentum as April closes, driven by hopes of easing trade tensions between China and the U.S. [1] - May presents a fresh opportunity for investors, particularly in penny stocks, as optimism around trade tariff resolutions builds [2][6] Company Analysis: Compass Therapeutics (NASDAQ: CMPX) - Compass Therapeutics has demonstrated strong stock performance in 2025, with a year-to-date increase of over 38%, currently trading at $1.94 [3][5] - The company is advancing its clinical pipeline, particularly with CTX-10726, a PD-1 x VEGF-A bispecific antibody, and plans to submit an IND by the end of 2025 [5][7] - Analysts predict a significant upside for CMPX, with a consensus "Buy" rating and an average price target of $12, indicating a potential increase of 527% over the next year [7] Company Analysis: Blade Air Mobility (NASDAQ: BLDE) - Blade Air Mobility operates a technology-enabled air transport platform, focusing on medical and passenger transportation, with expected double-digit growth in its medical business in 2025 [8] - The company has strengthened its financial position, achieving positive cash flow and maintaining a debt-free balance sheet with $136 million in cash, allowing for fleet growth and potential share buybacks [9] - Despite a recent rally of over 4% to $2.71, BLDE is down over 36% year-to-date, but analysts remain optimistic, forecasting a 117% upside with an average price target of $5.83 [9][11]